A common pathogenic founder variant in Rwandan breast cancer cases
PLOS Genetics · 02.11.2026 · 22 (11) · e1012180
DOI: 10.1371/journal.pgen.1012180 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Genetics, online erschienen am 02.11.2026. Verfasst von Achille V C Manirakiza und 15 weiteren Autor:innen. Beteiligte Einrichtung: Oncology Service, Department of Medicine, King Faisal Hospital Rwanda, Kigali, Rwanda. Hauptthemen laut MEDLINE: Breast Neoplasms, Founder Effect, BRCA1 Protein. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: U.S. Department of Defense.
Abstract (Originalsprache)
Germline data from African populations remain sparse, limiting characterization of population-specific BRCA1 /2 pathogenic variants (PV). In a study of 175 Rwandan women with breast cancer, 7 unrelated carriers (4% of cases; 22% of PV carriers) harbored the same BRCA1 frameshift PVs, c.4065_4068del (p.Asn1355Lysfs*10), which is extremely rare in gnomAD yet recurrent in European, Asian, and Middle Eastern cohorts. Whole-exome sequencing and haplotype analysis of all 7 carriers revealed a shared ancestral block of approximately 581 kb surrounding the variant, and extended haplotype homozygosity and network analyses confirmed a common founder origin. Coalescent-based age estimation placed the founder event approximately 4,000--10,000 years ago. Comparison with 1000 Genomes Project data showed the founder haplotype is absent or exceedingly rare outside African and South Asian populations. These findings strongly suggest the c.4065_4068del variant as a pre-historical BRCA1 founder variant in Rwanda, with implications for targeted genetic testing, cascade screening, and cancer prevention in the region.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Oncology Service, Department of Medicine, King Faisal Hospital Rwanda, Kigali, Rwanda.
- Africa Health Sciences University, Kigali, Rwanda.
- Center for Human Genetics and Genomics, School of Medicine and Pharmacy, College of Medicine and Health Sciences, University of Rwanda, Kigali, Rwanda.
- PMCC-AI, University Health Network, Toronto, Canada.
- Dana Farber Cancer Institute, Boston, Massachusetts, United States of America.
- Oncology department, Butaro Level II Teaching Hospital, Butaro, Rwanda.
ORCID-Profile: Achille V C Manirakiza, Brianna Bucknor, Diane R Koeller, Temidayo Fadelu
Förderung
- U.S. Department of Defense
Zitieren
APA
Manirakiza, A. V. C., Baichoo, S., Uwineza, A., Dukundane, D., Rugengamanzi, E., Mutamuliza, J., Niragira, A. M. O., Muvunyi, R., Besada, J., Nielsen, S. M., Bucknor, B., Koeller, D. R., Andrews, C., Mutesa, L., Fadelu, T., & Rebbeck, T. R. (2026). A common pathogenic founder variant in Rwandan breast cancer cases. PLOS Genetics, 22(11), e1012180. https://doi.org/10.1371/journal.pgen.1012180
Vancouver
Manirakiza AVC, Baichoo S, Uwineza A, Dukundane D, Rugengamanzi E, Mutamuliza J, et al. A common pathogenic founder variant in Rwandan breast cancer cases. PLOS Genetics. 2026;22(11):e1012180. doi:10.1371/journal.pgen.1012180
BibTeX
@article{Manirakiza2026,
author = {Manirakiza, Achille V C and Baichoo, Shakuntala and Uwineza, Annette and Dukundane, Damas and Rugengamanzi, Eulade and Mutamuliza, Janviere and Niragira, Allison M O and Muvunyi, Raissa and Besada, Jeffrey and Nielsen, Sarah M and Bucknor, Brianna and Koeller, Diane R and Andrews, Caroline and Mutesa, Leon and Fadelu, Temidayo and Rebbeck, Timothy R},
title = {A common pathogenic founder variant in Rwandan breast cancer cases},
journal = {PLOS Genetics},
year = {2026},
volume = {22},
number = {11},
pages = {e1012180},
doi = {10.1371/journal.pgen.1012180}
}
EUVIMED